Coronavirus | Opeds and editorials

What needs to be done with vaccines

Vaccines have proven to be effective against the SARS-CoV-2 virus in preventing serious illness and death. In an article published in Nature Medicine on June 9, an analysis of data from the United Kingdom, gathered between December 1, 2020 and April 30, 2021 when the alpha variant was predominant, showed that the AstraZeneca vaccine had an effectiveness of 64% after one dose and 79% after two doses, in protecting against severe illness and death. In the same article, the authors also found that a previous infection with SARS-CoV-2 had a significant protective effect against re-infection.

Vaccine data

On June 14, Public Health England released a report that showed that the AstraZeneca vaccine had an effectiveness of 71% after one dose and 92% after two doses in protecting from hospitalisation due to the delta variant. In the first report of vaccine effectiveness from India, researchers from the Christian Medical College, Vellore, Tamil Nadu, reported an analysis of 8,991 staff who had been vaccinated between January 21, 2021 and April 30, 2021, predominantly with Covishield, in the Mayo Clinic Proceedings. The protective effect of vaccination was 92% against need for oxygen and 94% against need for intensive care. There were no deaths, but about 10% of those who had received one or two doses were infected. Although sequencing was not available, many breakthrough infections were probably due to the delta variant strain. These data from the United Kingdom and India show that the Covishield vaccine is working against the variants.

Also read | Apollo Hospitals study ‘reiterates protective value of vaccination’

More detailed studies on whether the vaccines are continuing to work, if yes, for how long, or against new variants, will continue to be needed. We also need to consider what we expect from vaccines at different stages of the pandemic. At the level of the individual, we expect vaccines to be safe and provide protection from disease and death at least, and preferably also from mild disease and infection. From the point of view of public health, we expect vaccines to decrease the burden of illness and spread of infection. For society, however, beyond the needs of public health, the ability to go back to productivity and social interactions also matters. These different needs require policy approaches that balance the achievement of health and societal goals with the potential impact, and the exigencies of supply constraints.

In a time of urgent need and short supply, a clear and measurable goal is essential. The prioritisation and delivery strategy needs to align with the goal to achieve maximum impact. We have been somewhat confused about the goal, with early announcements of vaccinating 300 million people being replaced by all adults. With the increase in highly transmissible variants, it is clear that to both prevent disease and slow spread, we will need to cover a larger proportion of the population, possibly extending at a later stage to children.

On herd immunity

When vaccines seemed to be somewhere in the future with no predictability on timing or supply, discussions on the pandemic focused on ‘herd immunity’ or the percentage of the population that needed to be infected or vaccinated in order to slow the spread of infection. The Swedish strategy of limited restrictions and the Great Barrington declaration attracted much opprobrium as many scientific commentators considered it callous to follow a strategy which meant that a lot of people would get infected with the virus. Herd immunity or herd effect or herd protection is an often misunderstood term, but a key attribute is that the more transmissible the agent, the higher the level of the population that needs to be infected or vaccinated. With the delta variant, it is clear that the earlier plan to vaccinate a smaller proportion of the population is not appropriate and reaching up to 85% of the population might be necessary. This implies that not only will we have to consider all adults but we should be planning for children as well.

 

Long- and short-term goals

The control of infection in the population is the long-term goal. The short-term goal is to protect individuals at highest risk and to save lives. The deaths from COVID-19 show clearly that those who are the oldest are at the greatest risk of severe disease and mortality, with distinct stratification of severity by age, followed by those with comorbidities such as diabetes mellitus and hypertension. Yet, the risk of severe disease and death among younger people, though low, is not zero and therefore when large numbers of young people get infected some of them will die even with the best medical management. Nonetheless, the goal of preventing the maximum number of severe cases and deaths clearly requires an age descending approach.

This was indeed the strategy that was initially implemented in India, but the opening of the age tiers has not kept pace with the supply. The Government has not revealed a clear road map of availability of vaccines and their supply to individual States. This has highlighted the reluctance by the Government of India to reveal information which would help in formulating a predictable delivery mechanism that could be communicated to citizens. Coupled with the anti-science statements made by those seen as close to the Government, this has led to a situation where the public is confused as to how best to cope with the novel coronavirus pandemic. With the promise of vaccines as at least a partial solution, but with no certainty on availability, doubt, fear, anxiety and depression are widespread.

 

To move forward, we must accept that it is extremely unlikely that we will achieve the goal of vaccinating every adult by the end of 2021. Therefore, based on the principles of public health, we must vaccinate those most at risk from serious illness and death first. Based on population pyramid data, we can extrapolate that there are about 360 million above the age of 45 years. Even though recent data from the United Kingdom with the delta variant indicates a slightly lower effectiveness against severe disease requiring hospitalisation with a single dose (71% with one dose and 92% with two doses), the high rates of previous exposures in India may make it feasible to immunise a large part of our population with a single dose, at least initially.

Rural focus

The final prioritisation and approach should be modelled before policy is made and implemented, but for delivery, a rural focus is key. We must take the vaccine to every village, building on the experiences of the pulse polio programme and conducting elections. Community leaders should be empowered with information and tools to broadcast the message that the vaccine saves lives. The central government has centralised vaccine purchase but must revisit the private sector allocation and cede distribution to States, providing support when requested. The CoWIN app must not be a limiting factor on access to the vaccine.

 

Evidence, models, good data

As more vaccines become available the vaccination policy must be adapted quickly to changing circumstances. We must generate evidence and develop models to design the appropriate vaccination strategy for younger populations. If cases are climbing in a particular region, we should direct vaccine doses there to protect as much of the population as possible and decrease both disease and further spread. High vaccination coverage in cities may protect rural areas. Some professions are most likely to spread infection and should therefore be prioritised for vaccination.

Data | COVID-19 cases surge in rural India even as vaccination rates are lower than urban areas

Finally, the Government must trust its citizens and share the information that is solely available to it. A notable aspect of the pandemic is the absence of credible data from the government. This has led to speculative ideas based on poor or poorly understood information and misinformation. The management of the pandemic has been severely impacted by this lack of granular, interpretable, actionable data. We need to restore society to normalcy. Good data, or the ability to measure what matters, is the key.

Dr. George Thomas is the former editor of The Indian Journal of Medical Ethics; Dr. Gagandeep Kang is Professor, Wellcome Trust Research Laboratory at the Christian Medical College, Vellore; Dr. Jayaprakash Muliyil is former Principal of the Christian Medical College, Vellore


Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jul 24, 2021 2:17:10 PM | https://www.thehindu.com/opinion/lead/what-needs-to-be-done-with-vaccines/article34853438.ece

In This Package
A serosurvey template for the whole of India
Making decisions under stress
Dealing with denial: On playing down the COVID-19 tragedy
A cardinal omission in the COVID-19 package
Rising again: On global rise of fresh COVID-19 cases
Ramping up supply: On COVID-19 vaccination woes
Upholding trust in vaccination
Caution and optimism: On preventing the third wave
Countering the next wave of COVID-19
Stopping the surge: On unlock and the next COVID-19 wave
A welcome spike: On India’s COVID-19 vaccination record
A time to give: On ex-gratia compensation to families of COVID-19 victims
Focus on COVID-19 estimated deaths
You are reading
What needs to be done with vaccines
Counting the dead: On measuring excess deaths
Refocused vaccination campaigns are possible
Bring genomic sequencing into the pandemic fight
Preparing for the next COVID-19 wave
Connecting the dots to mitigate a third wave
The red flags on the trail of the virus
Behaviorial change can reduce transmission
Adverse changes, federalism imperilled
Close the vaccination gap, in global lockstep
Only a global effort can tame COVID-19
Addressing vaccine hesitancy
Naturally, selection: On vaccinating the vulnerable in 18+ group
Vaccination is our only weapon
Extending safety: On deferring second dose of COVID-19 vaccine
The AIDS fight offers a COVID vaccine patent pathway
The basics of an effective vaccine policy
Using all options: On Covaxin licensing
State action: On Centre’s role in COVID-19 fight
COVID mishandling foretold in the Budget
A matter of concern: On Indian coronavirus variant
Vaccine skirmishes: On production of COVID-19 vaccine
Lockdown gains: On need to augment health system
Social murder and the missing state
A CT scan for COVID merits a word of caution
To stop a third wave, India has to mask up
Is the government committed to vaccine equity?
Salutary steps: On Election Commission norms to curb COVID-19 spread
Shortage and wastage: On cutting vaccine wastage
Gasping for air, gasping for answers
Misinformed and misleading
Right priorities: On U.S. COVID-19 aid to India
A patently wrong regime
Tips for managing COVID-19 at home: the dos & don’ts
Undermining ‘vaccination for all’
Another wave spells more nutrition loss
Unfair and dangerous: On vaccine inequity
Viral load: On lockdowns, lives and livelihoods
The road ahead in India’s augmented vaccination drive
Infernal infernos: On hospital fires amid the pandemic
Too little: On the Election Commission’s COVID-19 curbs
India’s COVID crisis — when difficult became worse
A descent into disillusionment and chaos
Open and safe: On Modi government’s vaccination policy
A recipe for vaccine inequity
Vaccine diplomacy that needs specific clarifications
On the trail of the second wave’s dynamics
How can India contain the second wave?
Lessons from the first wave
Examination priorities: On annual exams amid the pandemic
The secrecy around deaths after vaccination
Indian universities need immediate vaccination
Lessons from COVID-19
The second wave: On why new COVID-19 vaccines should be cleared
Weighing in on the saga of a vaccine
Rising poverty: On pandemic-induced disparities
A booster shot for India’s vaccination plan
Allaying concerns: On public trust and vaccination programmes
A moral test: On the vaccine divide
Efficacious too: On Covaxin
Sustaining the drive: On COVID-19 vaccination phase 2
Vaccine inequities: On need to vaccinate all above 45
Addressing vaccine reluctance and policy hesitancy
Redefining the exit plan for COVID-19
Boosting confidence: On need for efficient use of COVID-19 vaccine stocks
Opening up the vaccine market
Origin and spread: On the source of SARS-CoV-2
New questions: On COVID-19 infecting one-fifth of Indian population
A year on, mind the gaps in the pandemic response
Should Board exams be conducted in one go this year?
No to vaccine nationalism, yes to global cooperation
Tempered optimism: On India’s sliding COVID-19 graph
The best shot against COVID-19
More vaccines than takers
Managing the rollout: On addressing vaccine hesitancy
Injecting confidence: On India’s COVID-19 vaccination drive
Vaccine optimism and the scientific uncertainty link
Building trust in vaccines
The debilitating side-effect of a flawed vaccine trial
Gearing up: On vaccines and public trust
A hurried gamble: On vaccines and transparency
The second dose: On COVID-19 vaccine
A constant vigil: On the new coronavirus strain in India
Unmasked, reflections on the pandemic and life
Caution pays: On Centre’s COVID-19 surveillance guidelines
Towards an effective vaccination distribution policy
Essential dry run: On COVID-19 vaccination drive
COVID-19 and limits of political accountability
The purpose of a vaccine
Clear the fog, draw up a clear vaccination policy
Rein in the vaccine nationalism, the profiteering
In vaccine race last lap, the key steps for India
The storage tale of two vaccines
T-cell immunity and COVID-19
COVID-19, climate and carbon neutrality
Signs of easing: On India’s COVID-19 fight
Has India passed the COVID-19 peak?
Sooner, better: On indigenously developed COVID-19 test kits
The battered Puja economy
Outline of a pandemic fight, by and for citizens
Pandemics and the collective consciousness
Vaccines with a global common good guarantee
Saving lives under the long shadow of the pandemic
Until vaccine: On Unlock 5
The challenge of changing health behaviour
Weighing the costs: On COVID-19 vaccine
The slow and frustrating journey of recovering from COVID-19
Health worker safety deserves a second look
Unlocking campuses: On UGC’s revised academic calendar
Recovery from COVID-19 can be a struggle
Uniting to combat COVID-19
Coronavirus fears and preconception advice
An agriculture-led revival as flawed claim
A necessary pause: On the COVID-19 vaccine race
The uncertainties over COVID-19 numbers
The challenges in counting the dead
COVID-19 deaths may be higher than reported
The many challenges in estimating deaths
Alone at the top: On India’s COVID-19 numbers
The participants we need in Phase 3 trials
Differential impact of COVID-19 and the lockdown
More than a vaccine, it is about vaccination
COVID-19 and a country club India must leave
A quest for order amid cyber insecurity
Adopting a public systems approach to COVID-19
Milestone of a million: On India’s COVID-19 numbers
Testing times: On university exams
Predictions, pandemics and public health
It’s time to flatten the pandemic stereotyping
Viral outrage only spikes the data
Sending the right message
Needed: Clear testing data
The social contract needs to be rewritten
The pandemic is about eyes shut
Joblessness and opportunity in Tamil Nadu
Green-lighting ecological decimation amidst a pandemic
COVID-19 has no religion
A case for extension: On rural jobs scheme
Surely, even if slowly: On a COVID-19 vaccine
Bend it like Italy: On flattening the COVID-19 curve
Promise and delivery: On India’s first COVID-19 vaccine
States hold the key: On Unlock 2.0
PCR testing is a double-edged sword
Science vs nonsense: On Patanjali’s COVID-19 claim
Shut and open: On tennis during the pandemic
The perils of follow the leader syndrome
The many questions about Favipiravir
In new lockdown, a second chance for Tamil Nadu
United front in Delhi: On Kejriwal government-Centre camaraderie
A prescription of equitable and effective care
Multilateralism post COVID-19
Making public transport safe during COVID-19
A better rate: On COVID-19 recovery
Look back in relief: On the migrant labour crisis
Needed, a transfusion for public health care
Wrong priorities: On keeping religious places open during a pandemic
Crossing the line: On Delhi’s decision to limit health services
Profit, not profiteering: On regulation of COVID-19 testing charges
In Persian Gulf littoral, cooperative security is key
Paging the private sector in the COVID fight
Curves and recoveries: On India’s coronavirus numbers
India’s Parliament is missing in action
Axing the economy’s trunk
Scripting a new narrative for COVID control
Open with caution: On Unlock 1
It’s time for a universal basic income programme in India
The waning of subaltern solidarity for Hindutva
Export blocks: On India’s trade amid the pandemic
A moment to trust the teacher
The echo of migrant footfalls and the silence on policy
Enjoying the fruits of their labour
Helping supply chains recover
The heavy burden of social suffering
An effective lockdown
The lockdown has highlighted stark inequalities
Will sport be the same in empty stadia?
Cinema after COVID-19
The eternal longing for the distant home
Working safely: On workplaces during the pandemic
A hole in the whole: On health sector woes
China, better prepared for the post-COVID world
How public health boosts an economy
Keep it retrospective
Backing the ‘angels in white coats’
Standstill: On opening of stadia for training
Flawed stimulus is justice denied
We need social physicians
A callous response
Peaking: On India’s coronavirus tally
Farm gate in focus: On amending Essential Commodities Act
A question of quarantine: On migrant workers and other travellers
TASMAC tribulations: On Tamil Nadu liquor sale
The pandemic and the challenge of behaviour change
One for the poor: On Centre’s corona package
Lockdown syndrome: On virus-induced economic crisis
Are India’s labour laws too restrictive?
Stop the return to laissez-faire
States cannot be left to the Centre’s mercy
Local motif: On Modi’s call for self-reliance
Liquidity lifeline: On Nirmala’s MSME package
A plan to revive a broken economy
Provide income support, restore jobs
Perilous state: On State finances
COVID-19 and the path ahead
Reaffirm cooperative federalism
Riding roughshod over State governments
Tragedy on the tracks: On the killing of 16 migrant workers
Coming to terms: On India refusing to admit community transmission
The trends shaping the post-COVID-19 world
The epidemic and ensuring safety in courts
Responding to COVID-19 at the grassroots
The face of exploitation
Contempt for labour: On dilution of labour laws
Slower growth and a tighter fiscal
Back home: On return of Indian expatriates
Blame game: On Donald Trump’s anti-China rhetoric over COVID-19
Resuscitating multilateralism with India’s help
A war-like state and a bond to the rescue
Fear and loathing in the land of the free
Everyone wants a good stimulus
Rent control amidst pandemic
Slow release: On lockdown 3.0
No comfort in numbers: On Bengal’s coronavirus cases
Pandemics without borders, South Asia’s evolution
India’s disease surveillance system needs a reboot
No relief for the nowhere people
BRICS against COVID-19
Recovering early: On India’s COVID-19 patients
It’s about food, nutrition and livelihood security
Taiwan’s coronavirus protocol shows how it is done
Needed: a pandemic patent pool
Getty Images/iStockphoto
Plasma therapy is no silver bullet
Take care of yourself too, fellow journalists
Strategic shift: On home isolation of mild coronavirus cases
Coping with today, planning for tomorrow
No end in sight: On India’s coronavirus strategy
Vividly imagining the life of migrant workers
A task for South Asia
Privacy concerns during a pandemic
Unlocking justice in the lockdown
Safe return: On migrant worker distress
The outline of another pandemic combat strategy
Pandemic and panic: On Tamil Nadu’s five-city lockdown
Protecting the poor from becoming poorer
Did SARS-CoV-2 begin from a lab?
Protection for protectors: On safety of healthcare workers
Rapid failures: On antibody testing kits
The COVID-19 paradox in South Asia
Fishing in troubled waters during a pandemic
How will India emerge out of the lockdown?
Making doctors wash hands
Locked out of cities, homes and livelihoods
Script of unity: On coronavirus and social prejudices
Exploiting a pandemic: On Trump’s immigration policy
The village is still relevant
A time for planetary solidarity
There may be no going back
No transparency in West Bengal
Focus on the curve: On India’s COVID-19 numbers
Economy in lockdown: On India’s worst case scenario
A shot of hope with a game changing vaccine
Caught in the heightened arc of communal polemics
Singing the corona tune
Helping a lending hand: On RBI’s second lockdown stimulus
A season of change: On IMD forecast system
A virus, social democracy, and dividends for Kerala
Across the gulf: On stranded Indian workers
Virtual reality: On telemedicine
A blueprint to revive the economy
A case to use JEE-Main instead of JEE-Advanced this year
Will the aviation industry recover from the pandemic?
Data-driven reporting during COVID-19
Stress test: On revised lockdown guidelines
Disastrous decision: On Trump halting funds to WHO
Cease the distractions, seize the moment
Getting the containment strategy in India right
In India’s response, a communications failure
Harmonising with nature
End the harassment of farmers now
A narrowing window: On extension of lockdown
Corona bond: On Eurozone COVID-19 rescue package
Halting the march of rumours
Polls during a pandemic
The pandemic and the contours of a health response
Economic liberalisation and its faults
Invasive, alien, most fearsome
Trade in tatters: On the global slump
Wanted, a collective national endeavour
Disingenuous and no antidote
COVID-19 and the crumbling world order
Women’s safety during lockdown
Lives and livelihoods: On economy after lockdown
Stage fright: On denying community transmission
Team India and winning the pandemic battle
In time of need: On hydroxychloroquine export
Will COVID-19 affect the course of globalisation?
Finding a scapegoat in WHO
Curating news for children during pandemic
A time for extraordinary action
For better use: On MPLADS funds
Needed, greater decentralisation of power
A key arsenal in rural India’s pandemic fight
Preparing for exit: On lifting the lockdown
Sanctions and pandemic: On America’s Iran policy
‘A script of action, responsibility and compassion’: Chief Minister Ashok Gehlot writes on Rajasthan’s fight against COVID-19
Taking a long view of the pandemic fight
Ten questions posed by the virus
A different economic approach
Why healthcare workers above 60 should be ‘benched’
Enemy at the gates: On Kerala-Karnataka border row
Reducing farm distress during a pandemic
Why everyone should wear masks
The criticality of community engagement
A niggardliness that is economically unwarranted
The spectre of a post-COVID-19 world
Light and sound: On Narendra Modi’s 9-minute light ceremony
A million and counting: On global coronavirus spread
Safe forests, safe people: On diseases of animal origin
Quarantine and the law
Making the private sector care for public health
Looking east to contain COVID-19
Limits to rugged individualism
Uncritical endorsement: On exodus of migrant workers and the Supreme Court
Beyond the blame game: On the Tablighi Jamaat episode
A long road: On India’s 21-day coronavirus lockdown
The missing notes: On politics and the fight against COVID-19
China’s zero: On China’s lead in containing coronavirus
Unprecedented step: On Wuhan lockdown
The return of the expert
Lessons from Hubei
A pandemic in an unequal India
Faith can’t override public health
Devising a people-centric response to COVID-19
Karnataka CM writes on how the State is fighting the pandemic
Tamil Nadu CM writes on how the State is stopping the pandemic in its tracks
The hunt for a cure begins with telling the truth
COVID-19 and a city’s anatomy
Long live the nation-state
The COVID cycle
Coronavirus | The worst of times, the best of times
It’s also a fight against punitive measures
The age of the neoliberal virus
The deep void in global leadership
Thinking national, acting local
Every man is a part of the main
Beyond social distancing to fight COVID-19
Next Story